JP2017536329A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536329A5
JP2017536329A5 JP2016531709A JP2016531709A JP2017536329A5 JP 2017536329 A5 JP2017536329 A5 JP 2017536329A5 JP 2016531709 A JP2016531709 A JP 2016531709A JP 2016531709 A JP2016531709 A JP 2016531709A JP 2017536329 A5 JP2017536329 A5 JP 2017536329A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
azaspiro
heterocycloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016531709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536329A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2014/095043 external-priority patent/WO2015101215A1/zh
Publication of JP2017536329A publication Critical patent/JP2017536329A/ja
Publication of JP2017536329A5 publication Critical patent/JP2017536329A5/ja
Pending legal-status Critical Current

Links

JP2016531709A 2013-12-31 2014-12-26 9,9,10,10−テトラフルオロ−9,10−ジヒドロフェナントレン類c型肝炎ウイルス阻害剤およびその応用 Pending JP2017536329A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310754318.4 2013-12-31
CN201310754318 2013-12-31
PCT/CN2014/095043 WO2015101215A1 (zh) 2013-12-31 2014-12-26 9,9,10,10-四氟-9,10二氢菲类丙型肝炎病毒抑制剂及其应用

Publications (2)

Publication Number Publication Date
JP2017536329A JP2017536329A (ja) 2017-12-07
JP2017536329A5 true JP2017536329A5 (enExample) 2018-01-25

Family

ID=53493209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016531709A Pending JP2017536329A (ja) 2013-12-31 2014-12-26 9,9,10,10−テトラフルオロ−9,10−ジヒドロフェナントレン類c型肝炎ウイルス阻害剤およびその応用

Country Status (9)

Country Link
US (1) US9512108B2 (enExample)
EP (1) EP3091010A4 (enExample)
JP (1) JP2017536329A (enExample)
KR (1) KR101857689B1 (enExample)
CN (2) CN105873922B (enExample)
AU (1) AU2014375584B2 (enExample)
CA (1) CA2935089C (enExample)
TW (1) TWI532735B (enExample)
WO (1) WO2015101215A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107266424A (zh) * 2016-04-07 2017-10-20 南京圣和药业股份有限公司 二氢菲类化合物及其制备方法
CN108623569A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物的制备方法
CN108623570A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 9,10-二氢菲类化合物、其制备方法及用途
CN108619102A (zh) * 2017-03-21 2018-10-09 南京圣和药业股份有限公司 一种包含丙型肝炎病毒抑制剂的药物组合物及其制备方法
CN108623568B (zh) * 2017-03-21 2022-04-19 南京汇诚制药有限公司 9,10二氢菲类丙型肝炎病毒抑制剂的盐型及其制备
CN109419806B (zh) * 2017-08-23 2023-06-20 南京圣和药业股份有限公司 抗病毒组合物及其应用
CN114890916A (zh) * 2022-04-25 2022-08-12 常州吉恩药业有限公司 一种n-甲氧羰基-l-叔亮氨酸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524230A1 (de) * 1995-07-04 1997-01-09 Hoechst Ag Fluorierte Phenanthren-Derivate und ihre Verwendung in flüssigkristallinen Mischungen
US6455744B1 (en) * 2001-01-23 2002-09-24 Air Products And Chemicals, Inc. Synthesis of vicinal difluoro aromatics and intermediates thereof
MX363732B (es) * 2009-05-13 2019-04-01 Gilead Pharmasset Llc Star Compuestos antivirales.
TWI548629B (zh) * 2010-11-17 2016-09-11 吉李德製藥公司 抗病毒化合物
CA2845321A1 (en) * 2011-08-24 2013-02-28 Glaxosmithkline Llc Combination treatments for hepatitis c

Similar Documents

Publication Publication Date Title
JP2017536329A5 (enExample)
JP2019524883A5 (enExample)
MY187617A (en) Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof
JP2016540742A5 (enExample)
RU2017111200A (ru) Циклогексилэтилзамещенные диаза- и триаза-трициклические соединения в качестве антагонистов индоламин-2,3-диоксигеназы для лечения рака
JP2016523270A5 (enExample)
JP2018537413A5 (ja) 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
JP2015143283A5 (enExample)
JP2013507425A5 (enExample)
JP2016521273A5 (enExample)
JP2015537020A5 (enExample)
JP2017537940A5 (enExample)
JP2011037841A5 (enExample)
JP2014501766A5 (enExample)
MX354175B (es) Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor activado de proteasa 4 (par4) para el tratamiento de agregacion plaquetaria.
JP2012092103A5 (enExample)
JP2015531773A5 (enExample)
JP2015514808A5 (enExample)
JP2012513416A5 (enExample)
RU2008143018A (ru) 5(гидроксиметилен-и аминометилен)замещенные пиримидины, ингибирующие вич
IN2014MN02657A (enExample)
JP2015522650A5 (enExample)
JP2015535839A5 (enExample)
JP2016506958A5 (enExample)
JP2015504081A5 (enExample)